We are live on ! Find out more
NDRA icon

ENDRA Life Sciences

11 hedge funds and large institutions have $6.06M invested in ENDRA Life Sciences in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

21% less funds holding

Funds holding: 1411 (-3)

22% less capital invested

Capital invested by funds: $7.75M → $6.06M (-$1.69M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

NDRA Hedge Fund Activity: Q3 2021 in Review

11 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2021, worth a combined $6.06M — down 22% from $7.75M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NDRA and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was State Street, adding an estimated $63.9K. The largest seller was Goldman Sachs, exiting entirely with an estimated $104K sold.

  • 11 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2021, down from 14 in Q2 2021.
  • Funds reported $6.06M of ENDRA Life Sciences stock for Q3 2021, down 22% quarter-over-quarter.
  • 0 funds opened new ENDRA Life Sciences positions in Q3 2021 and 3 closed out, a net change of -3 holders.
  • The largest ENDRA Life Sciences buyer in Q3 2021 was State Street, an estimated $63.9K added.
  • The largest ENDRA Life Sciences seller in Q3 2021 was Goldman Sachs, an estimated $104K sold.

Based on aggregated 13F filings for Q3 2021.